ARTICLE | Company News
Ablynx NV other research news
May 31, 2004 7:00 AM UTC
A nanobody targeting von Willebrand factor completely inhibited blood clotting when blood was passed between 2 glass plates at high speed (high shear). No inhibition was seen at low speeds. Ablynx sai...